未登录

D

David I. Min

taipei medical university

H指数:23

被引数:1,590

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

DIFFERENTIAL DETECTION OF GLYCOSYLATION OF HLA DONOR SPECIFIC ANTIBODIES (DSA) USING SINGLE ANTIGEN MICROBEADS

HUMAN IMMUNOLOGY

IF2.2

2018-10-010

PREAI

Association of genetic polymorphisms of macrophage inhibitory factor (MIF) and B-cell activating factor (BAFF) with the detection of donor specific antibodies in kidney allograft recipients

HUMAN IMMUNOLOGY

IF2.2

2017-10-013

PREAI

Renal Transplant Patients Biopsied for Cause and Tested for C4d, DSA, and IgG Subclasses and C1q: Which Humoral Markers Improve Diagnosis and Outcomes?

JOURNAL OF IMMUNOLOGY RESEARCH

IF3.6

2017-01-0123

OAAI

IGG SUBCLASS ANALYSIS IN C4D+DSA POSITIVE PATIENTS.

HUMAN IMMUNOLOGY

IF2.2

2015-10-010

PREAI

Relationship Between Interleukin-2 Polymorphism and BK Virus Infection After Kidney Transplantation.

TRANSPLANTATION

IF5

2014-07-010

PREAI

Impact of Inhibitor kappa B-alpha (IkB-α) Promoter Polymorphisms On the Risk of Cytomegalovirus Infection Among Hispanic Renal Transplant Recipients.

TRANSPLANTATION

IF5

2014-07-010

OAAI

Association of Interferon Gamma Gene Polymorphisms With BK Virus Infection Among Hispanic Renal Allograft Recipients

TRANSPLANTATION

IF5

2014-03-2714

OAAI

Influence of Cyclooxygenase-2 (COX-2) gene promoter-1195 and allograft inflammatory factor-1 (AIF-1) polymorphisms on allograft outcome in Hispanic kidney transplant recipients

HUMAN IMMUNOLOGY

IF2.2

2013-10-0116

PREAI

Association of Vitamin D Binding Protein Polymorphism With Long-Term Kidney Allograft Survival in Hispanic Kidney Transplant Recipients

TRANSPLANTATION

IF5

2012-11-010

OAAI

Genetic and Clinical Risk Factors of New-Onset Diabetes After Transplantation in Hispanic Kidney Transplant Recipients

西班牙肾移植受者移植后新发糖尿病的遗传和临床危险因素

TRANSPLANTATION

IF5

2011-05-2743

OAAI

Gender-dependent racial difference in disposition of cyclosporine among healthy African American and white volunteers

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2000-11-0175

PREAI

Safety and tolerability of cyclosporine microemulsion versus cyclosporine: Two-year data in primary renal allograft recipients - A report of the Neoral Study Group

TRANSPLANTATION

IF5

1997-03-0122

OA

Circadian variation of tacrolimus disposition in liver allograft recipients

TRANSPLANTATION

IF5

1996-10-0136

OA

Effect of grapefruit juice on cyclosporine pharmacokinetics in renal transplant patients

TRANSPLANTATION

IF5

1996-07-0146

OA

The safety and tolerability of cyclosporine emulsion versus cyclosporine in a randomized, double-blind comparison in primary renal allograft recipients

TRANSPLANTATION

IF5

1996-03-0143

OA

The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients

TRANSPLANTATION

IF5

1996-03-0194

OA